Psoriasis Clinical Trials in Phoenix

Showing 161-180 of 181 trials

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

NCT00162253

The purpose of this clinical research study is to learn if BMS-587101 is effective on the treatment of Moderate to Severe Psoriasis. The safety of this treatment will also be studied.

Psoriasis, Moderate to Severe

Bristol-Myers Squibb120 participantsStarted Apr 2005

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +13 more locations

COMPLETEDPhase 1/29.0 miles

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

NCT00126724

The 13G01 clinical trial is a Phase I/II dose escalation study designed to be conducted in adults with inflammatory arthritis who have persistent moderate or severe swelling in one or more joints, without a disease severe enough to warrant a change in regimen for the next three months. The study will permit subjects who are concurrently on anti-tumor necrosis factor (TNF)-alpha antagonists. For subjects on disease modifying antirheumatic drugs (DMARDs), a stable regimen for inflammatory arthritis for the previous three months, with no changes in doses in the four weeks prior to screening will be required. The primary objectives are: 1. to evaluate the safety of intra-articular administration of tgAAC94 in subjects currently taking TNF-alpha antagonists, and 2. to evaluate the safety of repeat intra-articular administration of tgAAC94 (gene therapy vector).

Arthritis, RheumatoidArthritis, PsoriaticAnkylosing Spondylitis

Targeted Genetics Corporation120 participantsStarted Aug 2005

Glendale, Arizona, United States • Tuscon, Arizona, United States • Palm Desert, California, United States +19 more locations

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects

Psoriasis Trials in Other Cities

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Continuation Study in Moderate to Severe Psoriasis

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Study for Adults With Plaque Psoriasis

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

Randomized Study of PH-10 for Psoriasis

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

An Exploratory Genetic Study in Participants With Psoriasis

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

Other Conditions in Phoenix